20th Conference on Retroviruses and Opportunistic Infections

The Conference on Retroviruses and Opportunistic Infections (CROI) is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world will in Atlanta for the 20th Conference on Retroviruses and Opportunistic Infections.

Below is a list of talks and posters by researchers associated with the Harvard AIDS Initiative and the Botswana-Harvard AIDS Institute Partnership.

Listed by day/time

Monday, March 4

SESSION 14 Implementation and Cost-effectiveness of Male Circumcision

1:30-2:30pm | B313 |
Uptake of Neonatal Male Circumcision as Part of HIV Prevention Efforts in Botswana: Maternal Motivators and Barrierse, Poster # 1011
Rebeca Plank, K.Wirth, N. Ndubuka, P. Kebaabetswe, C. Lesetedi, J.Makhema, D. Halperin, R. Shapiro, M.Mmalane, S.Lockman

SESSION 106 Randomized Trials of ART: A Potpourri

2:30-4pm | Hall B2
Efficiency of Different ARV Approaches after Virologic Failure on First-line Ritonavir-boosted Protease Inhibitor Regiments, Poster # 558
Yu Zheng, M. Hughes, S. Lockman, M. Hosseinipour, T. Campbell, R. Salata, R. Gulick, E. Daar, C. Benson, and J. Currier

SESSION 173 ART Strategies and Outcomes among Children

2:30-4pm | Hall B2
Growth among HIV Children Receiving ART:’Dar es Salaam, Tanzania, Poster # 945
Ramadhani Mwiru, D. Spiegelman, C. Duggan, G. Seage, H. Semu, G. Chalamilla, R. Kisenge, and W. Fawzi

Tuesday, March 5

SESSION 127 Emergence and Persistence of HPV-associated Malignancies in the ART Era

2:30-4pm | Hall B2 |
Incidence of AIDS-defining and Non-AIDS-defining Cancers following Expansion of ART: Botswana 2003-2008, Poster # 731
Scott Dryden-Peterson, H. Medhin, G. Seage, M.Pusoentsi, S. El-Halabi,T. Rebbeck, G. Suneja, M. Mmalane, M. Essex, and S. Lockman

SESSION 135 Risk Prediction, Risk Factors, Biomarkers, and Outcomes

2:30-4pm | HallB2 |
Significant Elevations in Interleukin-6 Levels as a Predictor of All-cause Mortality among Adults Receiving cART in Botswana: Results from a Clinical Trial , Poster # 780
Bethan McDonald, S. Moyo, L. Gabaitiri, S. Gaseitsiwe, H. Bussmann, J. Koethe, J. Makhema, R.Marlink, W. Wester, and M. Essex

SESSION 186 Implementation and Cost-effectiveness of Male Circumcision

2:30-4pm | HallB2 |
Uptake of Neonatal Male Circumcision as Part of HIV Prevention Efforts in Botswana: Maternal Motivators and Barrierse, Poster # 1011
Rebeca Plank, K.Wirth, N. Ndubuka, P. Kebaabetswe, C. Lesetedi, J.Makhema, D. Halperin, R. Shapiro, M. Mmalane, S. Lockman

SESSION 167 Breast Feeding and Prevention of Postnatal MTCT

2:30-4pm | HallB2 |
Predictors of Early Breastfeeding Cessation among HIV Women in the Mma Bana Study, Botswana, Poster # 927
Anthony Ogwu, S. Moyo, D. Kitch, J. Leidner, K. Powis, S. Lockman, J. Makhema, M. Pagano, M. Essex, and R. Shapiro

2:30-4pm | HallB2 |
Therapeutic Levels of Lopinavir in Late Pregnancy, and Abacavit Passage into Breast Milk: Mma Bana Study, Botswana, Poster # 932
R. Shapiro, S. Rossi, Anthony Ogwu, M. Moss, J. Leidner, S. Lockman, S. Moyo, J. Makhema, M. Essex, and E. Capparelli

Wednesday, March 6

Session 43 Advances in ARV and Anti-Hepatitis C Virus Therapy

10:45am | Ballroom 1-2 | Oral Abstract
Renal Insufficiency among Women Treated with Tenofovir/ Emtricitabine/Lopinavir/Ritonavir or Tenofovir/Emtricitabine/Nevirapine
A. Mwafongo, K. Nkanaunena, Mina Hosseinipour, S. Lockman, M. Hughes, J. Currier, and ACTG 5208

Session 46 Emergence and Persistence of HPV-associated Malignancies in the ART Era

1:30-2:30pm | B308 |
Incidence of AIDS-defining and Non-AIDS-defining Cancers following Expansion of ART: Botswana 2003-2008 Poster # 731
Scott Dryden-Peterson, H. Medhin, G. Seage, M.Pusoentsi, S. El-Halabi,T. Rebbeck, G. Suneja, M. Mmalane, M. Essex, and S. Lockman

Session 165 Pregnancy Complications among HIV Women

2:30-4pm | HallB2 |
Vitamin D Inadequacy in HIV Women on HAART Is Not Associated with Morbidity, Mortality, or Growth Impairment of Uninfected Infants: Botswana Poster # 920
Kathleen Powis, W. Fawzi, L. Smeaton, M. Hughes, S. Lockman, A. Ogwu, S. Moyo, J. Makhema, M. Essex, and R. Shapiro

Session 76 Neutralizing Antibodies and How to Stimulate Them

2:30-4pm | HallB2 |
X4 Virus Has Increased Resistance to Neutralization as Compared to Co circulating R5 Virus in HIV-1Subtype C Poster # 355
Nina Lin, C. Becerril, S. Moyo, J. Makhema, R. Musonda, M. Essex, S. Lockman, D. Kuritzkes, and M. Sagar

Session 145 TB: Incidence, Risk Factors, and Outcomes

2:30-4pm | HallB2 |
Body Mass Index and Advanced WHO Clinical Stage Are Predictors of TB Incidence among Patients on HAART in Botswana: Results from a Clinical Trial Poster # 830
Simani Gaseitsiwe, V. Maiswe, S. Moyo, H. Bussmann, W. Wester, R. Musonda, M. Mmalane, J. Makhema, R. Marlink, and M. Essex

Session 199 Virologic Failure, 2nd- and 3rd-line Therapy in RLS

2:30-4pm | HallB2 |
High Rates of Re-suppression among Patients with Viral Load Failure on 2nd-Line ART: Nigeria Poster # 1114
Holly Rawizza, B. Chaplin, S. Meloni, O. Agbaji, W. Gashau, P. Okonkwo, P. Kanki APIN PEPFAR Team